The age-associated decline of DNMT3A enhances IL-1α production, and disrupting IL-1R1 signaling early during tumor development normalized myelopoiesis and slowed the growth of lung, colonic, and pancreatic tumors. Here, DNMT3A is linked to pancreatic neoplasm.